Katrina Snow/ LinkedIn
Sep 17, 2026, 20:17
Katrina Snow: Whole Blood or Component Therapy – Which Would You Choose?
Katrina Snow, Transfusion Safety Officer at North York General Hospital, shared a post on LinkedIn:
“Picture this scenario: you have experienced a traumatic bleed and you need blood immediately. The clinical team caring for you has access to whole blood (LTOWB) and component therapy.
What do you want them to choose for you (whole blood vs. component therapy), and why?
For me (an RhD-negative female of childbearing potential) I’d be hoping they choose component therapy.”
Find more posts featuring Katrina Snow on Hemostasis Today.
-
Sep 17, 2026, 16:30Daria Camilli: Empowering Bleeding Disorder Advocacy Through Health Economics
-
Sep 17, 2026, 16:17Mehran Ghasemzadeh: Platelet NK Cell Crosstalk in Advanced Coronary Artery Disease
-
Sep 17, 2026, 16:16Barbara Adams Krolak: Do GLP-1s Affect Blood Clot Risk?
-
Sep 17, 2026, 15:46Heghine Khachatryan: Clinical Context at the Core of Thrombosis and Thrombophilia Management
-
Sep 17, 2026, 15:33Alexandros Makis: When Microcytic Anemia Has an Inherited Cause
-
Sep 17, 2026, 15:22α2-Antiplasmin Inhibition and the Future of Thrombolysis
-
Sep 17, 2026, 15:20Fatma M. Attia: Expanding the Evidence Base for Therapeutic Plasma Exchange Across Multiple Indications
-
Sep 17, 2026, 15:19Conan McIlwrath: The Haemophilia Society Engages With IBCA
-
Sep 17, 2026, 15:06Eleftheria Hatzimichael: A Contemporary Diagnostic Approach to Inherited Microcytic Anemias